Source Citation
Bernard GR, Vincent J-L, Laterre P-F, et al., for the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 8;344:699-709. https://pubmed.ncbi.nlm.nih.gov/11236773 (All 2001 articles were reviewed for relevancy, and abstracts were last revised in 2007.)
Revised Reference (2007)
- 1 Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C. An economic evaluation of activated protein C treatment for severe sepsis. New Engl J Med. 2002;347:993-1000. [PMID: 12324556] Google Scholar
Author, Article, and Disclosure Information
Authors:
Deborah J. Cook,
McMaster University, Hamilton, Ontario, Canada (D.J.C.)
University of British Columbia, Vancouver, British Columbia, Canada (J.A.R.)
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.